Research Article
Cost-Effectiveness of Oral Antidiabetic Drugs: A Prospective Multicenter Study of Real-World Patients
Figure 4
Risk factor-adjusted outcomes: efficacy, AE, and HRQoL. (a) HbA1c < 6.5%. (b) Hypoglycemia. (c) EQ-5D.
| (a) |
| (b) |
| (c) |
| (a) |
| (b) |
| (c) |